Basel, Switzerland

Erik Wallström

This inventor holds 4 USPTO granted patents and 8 published patent applications and 4 EPO patents. Top assignee: Novartis Ag. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Erik Wallström. Retrieved from https://idiyas.com/inventor/erik-wallstrom

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2021-2026

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Erik Wallström

Introduction

Erik Wallström is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of medicine, particularly in the treatment of multiple sclerosis. With a total of 4 patents to his name, Wallström's work is recognized for its innovative approaches to healthcare.

Latest Patents

One of Wallström's latest patents focuses on "Regimens and methods of treating multiple sclerosis using ofatumumab." This patent outlines treatment regimens that utilize the administration of ofatumumab, an anti-CD20 monoclonal antibody, to patients during both a loading dose regimen and a maintenance regimen. This innovative approach aims to improve the efficacy of treatments for multiple sclerosis, providing new hope for patients suffering from this condition.

Career Highlights

Erik Wallström is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to collaborate with other experts in the field, further enhancing the impact of his inventions. His dedication to advancing medical treatments has positioned him as a key figure in the pharmaceutical industry.

Collaborations

Wallström has worked alongside talented colleagues such as Marina Savelieva Praz and Algirdas Jonas Kakarieka Weisskopf. These collaborations have fostered a creative environment that encourages innovation and the development of groundbreaking treatments.

Conclusion

Erik Wallström's contributions to the field of medicine through his patents and collaborations highlight his commitment to improving patient care. His innovative approaches to treating multiple sclerosis demonstrate the potential for advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…